Supportive Care for the Head and Neck Cancer Patient

  • Sorin Buga
  • Chandana Banerjee
  • Jaroslava Salman
  • Marissa Cangin
  • Finly Zachariah
  • Bonnie Freeman
Part of the Cancer Treatment and Research book series (CTAR, volume 174)


Patients with head and neck cancers (HNC) face multiple psychosocial and physical challenges that require multidisciplinary attention and care throughout their disease process. The psychoemotional symptoms may be triggered by cosmetic disfigurement and/or functional deficits related to the cancer itself or cancer-directed treatments. These physical and emotional symptoms can be demoralizing and require acute and long-term professional assistance throughout a patient’s lifespan. HNC remains one of the most challenging cancers to treat due to disfigurement, emotional suffering, social isolation, and loss of self-esteem. The emotional and physical symptoms a supportive care team can address are discussed in this chapter.


Supportive care Palliative care Hospice End-of-life care 

Abbreviation List


Head and Neck Cancer


National Comprehensive Cancer Network


Major Depressive Disorder


End of Life


Ear, Nose, Throat

5-HT3 receptor

5-hydroxytryptamine receptor antagonists


Quality of Life


Central Nervous System



A special thank you to Karen Clark, MS of City of Hope for helping to analyze the data and assisting with content edits.


  1. 1.
    America CTCo. Palliative care for head and neck cancer. Accessed Sept 25, 2017
  2. 2.
    Lin YL, Lin IC, Liou JC (2011) Symptom patterns of patients with head and neck cancer in a palliative care unit. J Palliat Med. 14(5):556–559CrossRefPubMedGoogle Scholar
  3. 3.
    Ethunandan M, Rennie A, Hoffman G, Morey PJ, Brennan PA (2005) Quality of dying in head and neck cancer patients: a retrospective analysis of potential indicators of care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100(2):147–152CrossRefPubMedGoogle Scholar
  4. 4.
    Devins GM (2015) Head and Neck Cancer. In: Holland JC, Breitbart WS, Jacobsen PB, Loscalzo MJ, McCorkle R, Butow PN (eds) Psycho-Oncology (3rd edn). Oxford University Press, Oxford, 92–97Google Scholar
  5. 5.
    Neilson K, Pollard A, Boonzaier A et al (2013) A longitudinal study of distress (depression and anxiety) up to 18 months after radiotherapy for head and neck cancer. Psycho-oncology 22(8):1843–1848CrossRefPubMedGoogle Scholar
  6. 6.
    Holland JC, Andersen B, Breitbart WS et al (2010) Distress management. J Natl Compr Cancer Netw 8(4):448–485CrossRefGoogle Scholar
  7. 7.
    Loscalzo M, Clark K, Dillehunt J, Rinehart R, Strowbridge R, Smith D (2010) SupportScreen: a model for improving patient outcomes. J Natl Compr Cancer Netw 8(4):496–504CrossRefGoogle Scholar
  8. 8.
    Clark K, Bergerot CD, Philip EJ, Buga S, Obenchain R, Loscalzo MJ (2016) Biopsychosocial problem-related distress in cancer: examining the role of sex and age. Psycho-oncology, n/a-n/aGoogle Scholar
  9. 9. Body Image. Accessed 13 Sept 2016
  10. 10.
    Rhoten BA, Murphy B, Ridner SH (2013) Body image in patients with head and neck cancer: a review of the literature. Oral Oncol 49(8):753–760CrossRefPubMedGoogle Scholar
  11. 11.
    Gamba A, Romano M, Grosso IM et al (1992) Psychosocial adjustment of patients surgically treated for head and neck cancer. Head Neck 14(3):218–223CrossRefPubMedGoogle Scholar
  12. 12.
    Newell R (2000) Psychological difficulties amongst plastic surgery ex-patients following surgery to the face: a survey. Br J Plast Surg 53(5):386–392CrossRefPubMedGoogle Scholar
  13. 13.
    Rumsey N, Clarke A, White P, Wyn-Williams M, Garlick W (2004) Altered body image: appearance-related concerns of people with visible disfigurement. J Adv Nurs 48(5):443–453CrossRefPubMedGoogle Scholar
  14. 14.
    Low C, Fullarton M, Parkinson E et al (2009) Issues of intimacy and sexual dysfunction following major head and neck cancer treatment. Oral Oncol 45(10):898–903CrossRefPubMedGoogle Scholar
  15. 15.
    Fingeret MC, Vidrine DJ, Reece GP, Gillenwater AM, Gritz ER (2010) Multidimensional analysis of body image concerns among newly diagnosed patients with oral cavity cancer. Head Neck 32(3):301–309PubMedPubMedCentralGoogle Scholar
  16. 16.
    Fingeret MC, Yuan Y, Urbauer D, Weston J, Nipomnick S, Weber R (2012) The nature and extent of body image concerns among surgically treated patients with head and neck cancer. Psycho-oncology 21(8):836–844CrossRefPubMedGoogle Scholar
  17. 17.
    Fingeret MC, Teo I, Goettsch K (2015) Body image: a critical psychosocial issue for patients with head and neck cancer. Current Oncol Rep 17(1):422CrossRefGoogle Scholar
  18. 18.
    Rhoten BA, Deng J, Dietrich MS, Murphy B, Ridner SH (2014) Body image and depressive symptoms in patients with head and neck cancer: an important relationship. Support Care Cancer: official journal of the Multinational Association of Supportive Care in Cancer 22(11):3053–3060CrossRefGoogle Scholar
  19. 19.
    Katz MR, Irish JC, Devins GM, Rodin GM, Gullane PJ (2000) Reliability and validity of an observer-rated disfigurement scale for head and neck cancer patients. Head Neck 22(2):132–141CrossRefPubMedGoogle Scholar
  20. 20.
    Wu YS, Lin PY, Chien CY et al (2016) Anxiety and depression in patients with head and neck cancer: 6-month follow-up study. Neuropsychiatr Dis Treat 12:1029–1036CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Singer S, Krauss O, Keszte J et al (2012) Predictors of emotional distress in patients with head and neck cancer. Head Neck 34(2):180–187CrossRefPubMedGoogle Scholar
  22. 22.
    Smith JD, Shuman AG, Riba MB (2017) Psychosocial issues in patients with head and neck cancer: an updated review with a focus on clinical interventions. Current Psychiatry Rep 19(9):56CrossRefGoogle Scholar
  23. 23.
    Jabbour J, Milross C, Sundaresan P et al (2017) Education and support needs in patients with head and neck cancer: a multi-institutional survey. Cancer 123(11):1949–1957CrossRefPubMedGoogle Scholar
  24. 24.
    Chen AM, Daly ME, Vazquez E et al (2013) Depression among long-term survivors of head and neck cancer treated with radiation therapy. JAMA Otolaryngol Head Neck Surg 139(9):885–889CrossRefPubMedGoogle Scholar
  25. 25.
    Misono S, Weiss NS, Fann JR, Redman M, Yueh B (2008) Incidence of suicide in persons with cancer. J Clinic Oncol: official journal of the American Society of Clinical Oncology 26(29):4731–4738CrossRefGoogle Scholar
  26. 26.
    Kam D, Salib A, Gorgy G et al (2015) Incidence of Suicide in Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg 141(12):1075–1081CrossRefPubMedGoogle Scholar
  27. 27.
    Pattison N, Brown MR, Gubbay A et al (2016) Towards a pain free hospital: an in-depth qualitative analysis of the pain experiences of head and neck cancer patients undergoing radiotherapy. Br J Pain 10(1):29–37CrossRefPubMedGoogle Scholar
  28. 28.
    van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol: official journal of the European Society for Medical Oncology 18(9):1437–1449CrossRefGoogle Scholar
  29. 29.
    Whale Z, Lyne PA, Papanikolaou P (2001) Pain experience following radical treatment for head and neck cancer. Eur J Oncol Nurs: the official journal of European Oncology Nursing Society 5(2):112–120CrossRefGoogle Scholar
  30. 30.
    Feingold D, Goor-Aryeh I, Bril S, Delayahu Y, Lev-Ran S (2017) Problematic use of prescription opioids and medicinal cannabis among patients suffering from chronic pain. Pain medicine (Malden, Mass) 18(2):294–306Google Scholar
  31. 31.
    Scharpf J, Karnell LH, Christensen AJ, Funk GF (2009) The role of pain in head and neck cancer recurrence and survivorship. Arch Otolaryngol Head Neck Surg 135(8):789–794Google Scholar
  32. 32.
    Allal AS, Nicoucar K, Mach N, Dulguerov P (2003) Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head Neck 25(10):833–839; discussion 839–840Google Scholar
  33. 33.
    Bianchini C, Malago M, Crema L et al (2016) Post-operative pain management in head and neck cancer patients: predictive factors and efficacy of therapy. Acta otorhinolaryngologica Italica: organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 36(2):91–96Google Scholar
  34. 34.
    Lu W, Rosenthal DS (2013) Acupuncture for cancer pain and related symptoms. Curr Pain Headache Rep 17(3):321CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Sohl SJ, Stossel L, Schnur JB, Tatrow K, Gherman A, Montgomery GH (2010) Intentions to use hypnosis to control the side effects of cancer and its treatment. Am J Clinic Hypn 53(2):93–100CrossRefGoogle Scholar
  36. 36.
    Ing JW (2017) Head and neck cancer pain. Otolaryngol Clin North Am 50(4):793–806CrossRefPubMedGoogle Scholar
  37. 37.
    McMenamin EM, Grant M (2015) Pain prevention using head and neck cancer as a model. J Adv Pract Oncol 6(1):44–49PubMedPubMedCentralGoogle Scholar
  38. 38.
    Clarkson JE, Worthington HV, Eden OB (2007) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev (2):Cd001973Google Scholar
  39. 39.
    Miller RC, Le-Rademacher J, Sio TTW et al, A Phase III, Randomized double-blind study of doxepin rinse versus magic mouthwash versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy (Alliance A221304). Int J Radiat Oncol Biol Phys 96(5):938Google Scholar
  40. 40.
    Bur AM, Brant JA, Mulvey CL et al (2016) Association of clinical risk factors and postoperative complications with unplanned hospital readmission after head and neck cancer surgery. JAMA Otolaryngol Head Neck Surg 142(12):1184–1190CrossRefPubMedGoogle Scholar
  41. 41.
    Cohen EEW, LaMonte SJ, Erb NL et al (2016) American Cancer Society head and neck cancer survivorship care guideline. CA Cancer J Clin 66(3):203–239CrossRefPubMedGoogle Scholar
  42. 42.
    Quill TE (1998) Principle of double effect and end-of-life pain management: additional myths and a limited role. J Palliat Med. 1(4):333–336CrossRefPubMedGoogle Scholar
  43. 43.
    Khelemsky Y, Goldberg AT, Hurd YL et al (2017) Perioperative patient beliefs regarding potential effectiveness of marijuana (cannabinoids) for treatment of pain: a prospective population survey. Reg Anesth Pain Med 42(5):652–659CrossRefPubMedGoogle Scholar
  44. 44.
    Piper BJ, DeKeuster RM, Beals ML et al (2017) Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. J Psychopharmacol (Oxford, England) 31(5):569–575Google Scholar
  45. 45.
    Cote M, Trudel M, Wang C, Fortin A (2016) Improving quality of life with nabilone during radiotherapy treatments for head and neck cancers: a randomized double-blind placebo-controlled trial. Ann Otol Rhinol Laryngol 125(4):317–324CrossRefPubMedGoogle Scholar
  46. 46.
    Fallon MT, Albert Lux E, McQuade R et al (2017) Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies. Br J Pain 11(3):119–133CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Crowell TL (2016) Understanding Patients’ Process to Use Medical Marijuana: A Southern New Jersey Community Engagement Project. Journal of patient experience. 3(3):81–87CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Chwistek M (2017) Recent advances in understanding and managing cancer pain. F1000Research 6:945Google Scholar
  49. 49.
    Maher DP, Cohen SP (2017) Medical marijuana research for chronic pain. Lancet Psychiatry 4(7):513–515CrossRefPubMedGoogle Scholar
  50. 50.
    Maida V, Daeninck PJ (2016) A user’s guide to cannabinoid therapies in oncology. Current Oncol (Toronto, Ont) 23(6):398–406Google Scholar
  51. 51.
    Kroenke K, Cheville A (2017) Management of chronic pain in the aftermath of the opioid backlash. JAMA 317(23):2365–2366CrossRefPubMedGoogle Scholar
  52. 52.
    Elliott DA, Nabavizadeh N, Romer JL, Chen Y, Holland JM (2016) Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy. Support Care Cancer: official journal of the Multinational Association of Supportive Care in Cancer 24(8):3517–3524CrossRefGoogle Scholar
  53. 53.
    Zheng WK, Inokuchi A, Yamamoto T, Komiyama S (2002) Taste dysfunction in irradiated patients with head and neck cancer. Fukuoka igaku zasshi = Hukuoka acta medica 93(4):64–76Google Scholar
  54. 54.
    Ripamonti C, Zecca E, Brunelli C et al (1998) A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 82(10):1938–1945CrossRefPubMedGoogle Scholar
  55. 55.
    Caudell JJ, Schaner PE, Meredith RF et al (2009) Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 73(2):410–415CrossRefPubMedGoogle Scholar
  56. 56.
    Berger AM, Mooney K, Alvarez-Perez A et al (2015) Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw JNCCN 13(8):1012–1039CrossRefGoogle Scholar
  57. 57.
    Morrow GR (2007) Cancer-related fatigue: causes, consequences, and management. Oncologist 12(Suppl 1):1–3CrossRefPubMedGoogle Scholar
  58. 58.
    Vandaveer J. Fatigue. HospiScript Services; 2015Google Scholar
  59. 59.
    Mucke M, Cuhls H, Peuckmann-Post V, Minton O, Stone P, Radbruch L (2015) Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev (5):Cd006788Google Scholar
  60. 60.
    Bower JE, Bak K, Berger A et al (2014) Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clinic Oncol: official journal of the American Society of Clinical Oncology 32(17):1840–1850CrossRefGoogle Scholar
  61. 61.
    Spathis A, Fife K, Blackhall F et al (2014) Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clinic Oncol: official journal of the American Society of Clinical Oncology 32(18):1882–1888CrossRefGoogle Scholar
  62. 62.
    Grauer PA. Dyspnea. HospiScript Services; 2015Google Scholar
  63. 63.
    Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC monographs on the evaluation of carcinogenic risks to humans 2012;100(Pt E):1–538Google Scholar
  64. 64.
    Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clinic Oncol: official journal of the American Society of Clinical Oncology 29(32):4294–4301CrossRefGoogle Scholar
  65. 65.
    Blot WJ, McLaughlin JK, Winn DM et al (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Can Res 48(11):3282–3287Google Scholar
  66. 66.
    Ostroff JS, Jacobsen PB, Moadel AB et al (1995) Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 75(2):569–576CrossRefPubMedGoogle Scholar
  67. 67.
    Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC (1991) Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control: CCC 2(2):105–112CrossRefPubMedGoogle Scholar
  68. 68.
    Dresler CM, Bailey M, Roper CR, Patterson GA, Cooper JD (1996) Smoking cessation and lung cancer resection. Chest 110(5):1199–1202CrossRefPubMedGoogle Scholar
  69. 69.
    Davison AG, Duffy M (1982) Smoking habits of long-term survivors of surgery for lung cancer. Thorax 37(5):331–333CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Walker MS, Larsen RJ, Zona DM, Govindan R, Fisher EB (2004) Smoking urges and relapse among lung cancer patients: findings from a preliminary retrospective study. Prev Med 39(3):449–457CrossRefPubMedGoogle Scholar
  71. 71.
    Parsons A, Daley A, Begh R, Aveyard P (2010) Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 340:b5569CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Kawahara M, Ushijima S, Kamimori T et al (1998) Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer 78(3):409–412CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Do KA, Johnson MM, Doherty DA et al (2003) Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control CCC 14(2):131–138CrossRefPubMedGoogle Scholar
  74. 74.
    Browman GP, Wong G, Hodson I et al (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328(3):159–163CrossRefPubMedGoogle Scholar
  75. 75.
    Zhang J, Kamdar O, Le W, Rosen GD, Upadhyay D (2009) Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol 40(2):135–146CrossRefPubMedGoogle Scholar
  76. 76.
    Zevallos JP, Mallen MJ, Lam CY et al (2009) Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer 115(19):4636–4644CrossRefPubMedGoogle Scholar
  77. 77.
    Arcavi L, Benowitz NL (2004) Cigarette smoking and infection. Arch Intern Med 164(20):2206–2216CrossRefPubMedGoogle Scholar
  78. 78.
    Moller AM, Pedersen T, Villebro N, Schnaberich A, Haas M, Tonnesen R (2003) A study of the impact of long-term tobacco smoking on postoperative intensive care admission. Anaesthesia 58(1):55–59CrossRefPubMedGoogle Scholar
  79. 79.
    Smith JB, Fenske NA (1996) Cutaneous manifestations and consequences of smoking. J Am Acad Dermatol 34(5 Pt 1):717–732; quiz 733–714Google Scholar
  80. 80.
    Berg CJ, Thomas AN, Mertens AC et al (2013) Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psycho-oncology 22(4):799–806CrossRefPubMedGoogle Scholar
  81. 81.
    Freedman ND, Schatzkin A, Leitzmann MF, Hollenbeck AR, Abnet CC (2007) Alcohol and head and neck cancer risk in a prospective study. Br J Cancer 96(9):1469–1474CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Alcohol consumption and ethyl carbamate. IARC monographs on the evaluation of carcinogenic risks to humans. 2010;96:3-1383Google Scholar
  83. 83.
    Tilley C, Lipson J, Ramos M (2016) Palliative wound care for malignant fungating wounds: holistic considerations at end-of-life. Nurs Clinic N Am 51(3):513–531CrossRefGoogle Scholar
  84. 84.
    Serious Illness Care Resources (2017) Accessed 25 Sept 2017
  85. 85.
    VitalTalk [computer program] (2017)Google Scholar
  86. 86.
    Connor SR (2013) The family, larger systems and the dying process. In: Meagher DK, Balk DE (eds) Handbook of thanatology: the essential body of knowledge for the study of death, dying, and bereavement. Taylor & Francis, pp 33–49Google Scholar
  87. 87.
    Houvras Y, Nagarkatti S, Wirth LJ (2011) Multidisciplinary management of thyroid cancer. In: Haddad R (ed) Multidisciplinary management of head and neck cancer. Demos Medical Publishing L.L.C., New York, pp 161–177Google Scholar
  88. 88.
    Freeman B (2015) Compassionate person-centered care of the dying: an evidence based palliative care guide for nurses. Springer Publishing Company, LLC, New YorkGoogle Scholar
  89. 89.
    Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K (2007) Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manag 33(3):238–246CrossRefGoogle Scholar
  90. 90.
    Kelley AS, Meier DE (2010) Palliative care—a shifting paradigm. N Engl J Med 363(8):781–782CrossRefPubMedGoogle Scholar
  91. 91.
    Berry LL, Connor SR, Stuart B (2017) Practical ideas for improving the quality of hospice care. J Palliat Med 20(5):449–452CrossRefPubMedGoogle Scholar
  92. 92.
    Price KA, Moore EJ, Moynihan T, Price DL (2009) Symptoms and terminal course of patients who died of head and neck cancer. J Palliat Med 12(2):117–118CrossRefPubMedGoogle Scholar
  93. 93.
    Freeman B (2015) Sedation for refractory symptoms. In: Ferrell B, Coyle N, Paice J (eds) HPNA palliative nursing manual: care of the imminently dying. Oxford University Press, New YorkGoogle Scholar
  94. 94.
    Garcia-Egido AA, Payares-Herrera MC (2011) Managing hemorrhages in patients with head and neck carcinomas: a descriptive study of six years of admissions to an internal medicine/palliative care unit. J Palliat Med 14(2):124–125CrossRefPubMedGoogle Scholar
  95. 95.
    Balfe M, O’Brien KM, Timmons A et al (2016) Informal caregiving in head and neck cancer: caregiving activities and psychological well-being. Eur J Cancer CareGoogle Scholar
  96. 96.
    Maltoni M, Pittureri C, Scarpi E et al (2009) Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Ann Oncol 20(7):1163–1169CrossRefPubMedGoogle Scholar
  97. 97.
    Bobb B (2016) A review of palliative sedation. Nurs Clinic N Am 51(3):449–457CrossRefGoogle Scholar
  98. 98.
    Brajtman S, Wright D, Hogan DB et al (2011) Developing guidelines on the assessment and treatment of delirium in older adults at the end of life. Can Geriatr J CGJ 14(2):40–50PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Sorin Buga
    • 1
  • Chandana Banerjee
    • 1
  • Jaroslava Salman
    • 1
  • Marissa Cangin
    • 1
  • Finly Zachariah
    • 1
  • Bonnie Freeman
    • 1
  1. 1.Department of Supportive CareCity of HopeDuarteUSA

Personalised recommendations